Daxor Corporation
DXR
Daxor Corporation is a medical device manufacturing company which provides additional biotechnology services. Daxor Corporation was originally incorporated in New York State as Iatric Corporation in May 1971 for cryobanking services and continues these services through its wholly-owned subsidiary, Scientific Medical Systems.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1M
▼ -8.4% YoY
Net Income (TTM)
-$7M
▼ -244.6% YoY
Op. Margin
-400.07%
▼ -41.7pp YoY
ROIC
-10.92%
▼ -1.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▼ -10.3% YoY
Op. Cash Flow (TTM)
-$7M
▼ -14.4% YoY
Net Debt
-$56M
Net Cash Position
Cash & Equiv.
$56M
Continue Research
Daxor (DXR) in four numbers
Questions about Daxor
Is Daxor (DXR) overvalued?
At $7.45, Daxor's price is 44% above the $5.18 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Daxor's fair value?
Intrinsiqq's calculator puts Daxor's fair value at $5.18 a share. It grows revenue per share 5% a year for 5 years, applies an exit P/S of 15, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $3.89. Every input can be changed on the Intrinsic Value tab.
Is Daxor a high-quality business?
Daxor scores 18 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is net debt at -$56M, and its weakest is return on capital at -10.9%. The Quality tab shows every check against its target.
Does Daxor (DXR) pay a dividend, and how much?
Yes. Daxor (DXR) pays a dividend: $0.25 per share over the last twelve months, a dividend yield of 3.37% at the latest close. The Dividends tab has the full payment history and the safety score.
Source: 10-K filed 28 Mar 2012 (period ending 31 Dec 2011), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in DXR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DXR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.